Luis Martínez-Dolz

Luis Martínez-Dolz is an expert in Cardiology at Hospital Universitari i Politècnic La Fe (Spain). As of October 2026, ScienceLeadR ranks Luis Martínez-Dolz in the top 1% of experts in Spain for Heart Transplantation. Luis Martínez-Dolz has authored 428 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 3 of them ongoing. SLR score: 1,095 (community average: 125). How the SLR is computed.

Cardiology

Subspecialties: Biochemistry - Public Health - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on October 7, 2026

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2001 - 2026

Source: PubMed

Hospital Universitari i Politècnic La Fe

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 428

Citations

Citations: 5 135 1st author: 16 Last author: 50 Unique author: 1

Main journals

Rev Esp Cardiol 84

Transplant Proc 84

Rev Esp Cardiol (Engl Ed) 19

J Heart Lung Transplant 16

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title	Journal	Year
Decisions in Diuretic Resistance: Oral or Subcutaneous Furosemide in Advanced Ambulatory Heart Failure? PMID 42792852 — creatinine, serum, heart failure, heart, solutions, diuretics, furosemide, outpatients	Biomedicines	2026
Evolution of CA 125 and NT-proBNP in stable patients with Fontan circulation: longitudinal analysis with sex perspective. PMID 42701474 — research design, heart failure, heart, biomarkers, sex, outpatients	Int J Cardiol Congenit Heart Dis	2026
Standardizing Vegetation Size Measurement in Native Left-Sided Infective Endocarditis Using Artificial Intelligence. PMID 42589910 — research design, intelligence, decision making, endocarditis, echocardiography, artificial intelligence	J Clin Med	2026
Fibrosis Process Activation in Patients with Acute Cardiac Rejection: A Novel Noninvasive Diagnostic Approach. PMID 42351799 — serum, myofibroblasts, fibrosis, heart transplantation, transplants, fibroblasts	Biomedicines	2026
Drug-coated balloons vs drug-eluting stents for the treatment of large native coronary artery disease. Meta-analysis of randomized controlled trials. PMID 42087868 — stents, drug-eluting stents, coronary artery disease, pharmaceutical preparations, arteries, therapeutics	REC Interv Cardiol	2025

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 2 2

Phase 4 2

N/A 1

Phase 3 1

By status:

Completed 2

Recruiting 2

Active not recruiting 1

Terminated 1

By type:

Interventional 6

By Monocentric/Multicentric:

monocentric 2

multicentric2to4 1

multicentric5to9 1

multicentricup10 2

Main Topics

Cardiovascular Diseases 4

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study	Phase	Status	Start
Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy (REMOVE) 2023-504946-70-00 — heart failure, heart, cardiac resynchronization therapy, therapeutics	Phase 4	Active not recruiting	2021
Plaque Modification And Impact On Microcirculatory Territory After Drug Coated Balloon Percutaneous Coronary Intervention (PLAMI) NCT06080919 — myocardial ischemia, stents, physiology, drug-eluting stents, coronary artery disease, pharmaceutical preparations, percutaneous coronary intervention, angiography, arteries, coronary disease, software, ischemia, pulse	N/A	Recruiting	2022
Uninterrupted Direct acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures NCT05292846 — anticoagulants, hemorrhage, coronary artery disease, rivaroxaban, arteries, dabigatran, apixaban, edoxaban	Phase 4	Recruiting	2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS

Shopping Cart

System Maintenance Notice